The FBI Took Martin Shkreli But They Left His Wu-Tang Album

Probably Shmurda shouldn’t hold his breath, considering Shkreli was just released from jail on million bond after a Thursday hearing.

Online, many people took instant glee in his arrest, some of them joking about a judge ratcheting up his sentence or lawyers jacking up their hourly fees 5,000 percent for defending him in his hour of need.

Bloomberg News said Shkreli’s lawyer and a spokesman for Retrophin didn’t immediately respond to requests for comment.

It said they fraudulently induced investors to sink their money into two separate funds and misappropriated Retrophin’s assets to satisfy Mr Shkreli’s personal and professional debts. No one except the purchaser have ever heard the album, and Shkreli said before his arrest that he would never play it for anyone for free unless they served him up sexual favors. He made “made material misrepresentations and omissions to investors and prospective investors” during this time, the complaint said. According to Buzzfeed, “Federal prosecutors allege that he lied about the success of the company in order to earn the funds to pay off investors, which resulted in the loss of $11 million”. On Thursday, the 32-year-old Wall Street player became the subject of schadenfreude on a mass scale with the news that he had been arrested for securities fraud.

A handcuffed Evan Greebel walked out of the FBI’s NY headquarters a few steps ahead of ex-Retrophin Inc.

The drug combats toxoplasmosis, an infection that can arise in children because of poor immune systems, as well as patients suffering from AIDS and some form of cancers. Although it’s hard to tell if it’s meant to be satire or a legitimate call for Shkreli to be let go.

The uproar over price hikes at Turing and by other companies like Valeant Pharmaceuticals led to government investigations, proposals by politicians to fight “price gouging”, heavy media scrutiny and a drop in stock prices for biotech companies. Donald Trump called Shkreli “a spoiled brat”. Hillary Clinton, Bernie Sanders et al naturally rushed to make this jerk the face of the pharmaceutical industry, or capitalism itself.

Shkreli said the company would cut the drug’s price. But last month Turing reneged. Although the company promised to reduce the price, in November, it mentioned that it won’t but would instead offer concessions like volume discounts.

Shkreli defended the increase by saying that insurance and other programs would enable patients to get the drug and that the profits would help fund research into new treatments.

He also promised to lower the price of Daraprim but reportedly never did.

“A new chapter for Retrophin began the day the company replaced Martin Shkreli more than a year ago – and that decision has been vindicated by today’s indictment”, said the company’s statement.

One person went with another musical reference, Karma Police by Radiohead, to express his thoughts on Shkreli.